Recognizing the catastrophic impact of USA funding cuts on the South African Health Research Enterprise since early 2025, the SAMRC raised substantial funding to support affected institutions/organisations and ran a Request for Applications (SAMRC-RFA-GIPD-04-2025), issued on 29 July 2025, for this purpose. The SAMRC is currently finalising around 60 grants with an estimated budget of around R226 million from this RFA.

The South African Medical Research Council (SAMRC) is pleased to announce the launch of the 1st Joint Transnational Call for proposals under the European Partnership on One Health Antimicrobial Resistance (EUP OHAMR). The call aims to develop innovative, cost-effective treatment options for antimicrobial resistance (AMR). This is an international call for proposals co-funded by the European Union and 37 national and regional funding organisations from 28 countries, with an estimated total call budget of over 31 million Euro.

The South African Medical Research Council’s (SAMRC) Division of Research Capacity Development (RCD) is pleased to request applications from mid-career scientists in health/medical research. The SAMRC Mid-Career scientist Programme is an excellent opportunity for South African academic institutions to support future health research leaders to grow their own research teams and make the transition to independent researchers.

The South African Medical Research Council (SAMRC) in collaboration with the Technology Innovation Agency (TIA) is pleased to announce the release of its 6th SAMRC-TIA Seed Fund (SAMRC-TSF) call, for the 2025/26 FY. The purpose of the SAMRC-TSF is to assist innovators who are developing new products to complete product design and optimise prototypes, based on market feedback, to meet regulatory requirements and to complete other activities towards market-ready products. This call is specifically aimed at fostering academia and industry collaborative technology development that results in joint intellectual property (IP) that can be commercialised for the benefit of society.

The European Partnership for Personalised Medicine, EP PerMed, supported by the European Union under Horizon Europe, Grant Agreement N° 101137129, has launched its first research, innova-tion and technology call (RITC2026) for proposals on “Test and Demonstration of Multimodal Data Approaches for Personalised Medicine”, acronym “MultiPMData2026”. In total, 19 funding organisa-tions participate in this call with an available budget of over 1 4.8 Mio. € (approx.). EP PerMed funding organisations, listed below, have agreed to jointly fund multinational innovative research and technology projects in personalised medicine (PM) to encourage innovative, interdisciplinary public-private partnerships and to support the translational and clinical implementation of research outcomes.

Together with the Australian National Health and Medical Research Council (NHMRC), the South African Medical Research Council (SAMRC) is inviting investigators to submit applications with a focus on implementation research, addressing strategies for strengthening of health systems to improve equity in high quality care and health outcomes and reduce the prevalence and impact of non-communicable diseases.